BioSpace News Archive

BioMidwest

Healthcare Wipes to Grow 3.8% Annually Through 2023

Demand for wipes used in healthcare settings is expected to increase 3.8% per year to $594 million in 2023

October 21, 2019
·
2 min read
FDA

FDA approves new breakthrough therapy for cystic fibrosis

The U.S. Food and Drug Administration today approved Trikafta (elexacaftor/ivacaftor/tezacaftor), the first triple combination therapy available to treat patients with the most common cystic fibrosis mutation

October 21, 2019
·
5 min read
FDA

FDA Approves TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Treat the Underlying Cause of Cystic Fibrosis in People Ages 12 and Older Who Have at Least One F508del Mutation

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved TRIKAFTA™ (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for the treatment of cystic fibrosis (CF) in people ages 12 years and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, the most common CF-causing mutation.

October 21, 2019
·
10 min read
Biotech Bay

Align Technology’s Invisalign Brand Announced as Official Smile of the Carolina HurricanesAgreement promotes winning smiles and support for youth hockey program

Align Technology, Inc., makers of the Invisalign clear aligner system, announced a new agreement with the NHL’s Carolina Hurricanes, bringing together two powerful brands based in the Raleigh, North Carolina area.

October 21, 2019
·
3 min read